Acral Lentiginous Melanoma, also known as malignant acral lentiginous melanoma, is related to paronychia and skin melanoma, and has symptoms including macule An important gene associated with Acral Lentiginous Melanoma is BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase), and among its related pathways/superpathways are ERK Signaling and Signal Transduction. The drugs Sunitinib and Relatlimab have been mentioned in the context of this disorder. Affiliated tissues include skin and lymph node, and related phenotypes are Decreased substrate adherent cell growth and homeostasis/metabolism